Most recently, Dr Hensby served as the vice president of R&D and regulatory affairs for Ivrea Pharmaceuticals. Dr Hensby is a graduate BSc in pharmacology from Kings College, London and researched his PhD at Edinburgh University.
Jeffrey Day, president and CEO of Quinnova, said: “We are extremely pleased to have another leader of Chris’s caliber join the Quinnova management team. He brings expertise both in the development of products in dermatology and podiatry markets plus compliance in international clinical and regulatory affairs.”